Mygrin Nighttime
NDC Package 49467-230-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mygrin Nighttime is for the temporary relief of occasional headaches, and minor aches and pains, with accompanying sleeplessness. Marketed by Sunascen Therapeutics Llc, this product is identified by NDC 49467-230 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
49467-230-10
Package Description
1 BOTTLE in 1 CARTON / 100 TABLET, FILM COATED in 1 BOTTLE
Product Code
49467-230
11-Digit Billing Format
49467023010
RxNorm Crosswalk
  • RxCUI: 1593110 - acetaminophen 250 MG / aspirin 250 MG / diphenhydrAMINE citrate 38 MG Oral Tablet
  • RxCUI: 1593110 - acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet
  • RxCUI: 1593110 - APAP 250 MG / ASA 250 MG / Diphenhydramine Citrate 38 MG Oral Tablet

Clinical Specifications

Proprietary Name
Mygrin Nighttime
Dosage Form
-
Usage Information
For the temporary relief of occasional headaches, and minor aches and pains, with accompanying sleeplessness

Regulatory & Marketing

Labeler Name
Sunascen Therapeutics Llc
FDA Application #
part343
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
02-05-2018
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49467-230-10 identifies a specific commercial package of 1 bottle in 1 carton / 100 tablet, film coated in 1 bottle of Mygrin Nighttime, labeled by Sunascen Therapeutics Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sunascen Therapeutics Llc on February 05, 2018. The current certification is valid through December 31, 2024.

How is this Sunascen Therapeutics Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49467023010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49467-230-10
11-Digit CMS (5-4-2)
49467-0230-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.